SUVRETTA CAPITAL MANAGEMENT, LLC - 19 Nov 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director, 10%+ Owner
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer
Issuer symbol
BNTC
Transactions as of
19 Nov 2024
Net transactions value
+$416,616
Form type
4
Filing time
21 Nov 2024, 16:24:23 UTC
Previous filing
30 Sep 2024
Next filing
05 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNTC Common stock, par value $0.0001 per share Purchase $120,944 +12,430 +0.16% $9.73 7,895,815 19 Nov 2024 See footnotes F1, F2
transaction BNTC Common stock, par value $0.0001 per share Purchase $15,276 +1,570 +0.17% $9.73 947,238 19 Nov 2024 See footnotes F1, F3
transaction BNTC Common stock, par value $0.0001 per share Purchase $248,959 +24,360 +0.31% $10.22 7,920,175 20 Nov 2024 See footnotes F1, F4
transaction BNTC Common stock, par value $0.0001 per share Purchase $31,437 +3,076 +0.32% $10.22 950,314 20 Nov 2024 See footnotes F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Notes are included on Exhibit 99.1.
F2 Notes are included on Exhibit 99.1.
F3 Notes are included on Exhibit 99.1.
F4 Notes are included on Exhibit 99.1.
F5 Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature